NewYork Medical College

Hawthorne, New York 10595

3 studies enrolling now · 28 studies all time

What they study most

Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Asthma, Bladder Cancer, Central Nervous System Embryonal Tumors, Chronic Fatigue Syndrome, Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation, Diffuse Large B-Cell Lymphoma, Drug Resistant Epilepsy

Studies at this site

• American Lung Association (ALA) Lung Health Cohort — Recruiting now
• Study With Phage for CF Subjects With Pseudomonas Lung Infection — Recruiting now
• Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation — Completed
• HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors — Running, not enrolling
• Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis — Running, not enrolling
• Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma — Running, not enrolling
• Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta — Running, not enrolling
• A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis — Completed
• Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection — Completed
• Engineering Evaluation of the Helix Ventilator — Completed
• Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies — Available (expanded access)
• Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ — Completed
• Feasibility Study of the Reia Vaginal Pessary — Completed
• Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients — Completed
• Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia — Stopped early
• Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) — Completed
• Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations — Withdrawn before enrolling
• Chemoreflex and Baroreflex Alterations Causing Postural Tachycardia Syndrome With Orthostatic Hyperpnea and Hypocapnia — Status unconfirmed
• Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis — Completed
• A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) — Stopped early
• Study of AMV564 in Patients With AML — Completed
• Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients — Status unconfirmed
• A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis — Completed
• Study Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma — Completed
• Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease — Completed
• Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR Mutation — Stopped early
• Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer — Stopped early
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed